Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2021-08-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$384.9m reported value +5.0% vs Q1 2021
15positions
88.8%in top 10
0 new 10 added 2 reduced 0 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 1,813,392 $67.7m17.58% 17.58% AddedShares held: Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 1.7m, Q2 2021 1.8m +108.0k +108,000 6.3%
2 SPERO THERAPEUTICS INC COM SPRO SPRO 3,829,209 $53.5m13.89% 13.89% UnchangedShares held: Q3 2020 4.5m, Q4 2020 3.9m, Q1 2021 3.8m, Q2 2021 3.8m
3 BLUEPRINT MEDICINES CORP COM BPMC BPMC 448,512 $39.5m10.25% 10.25% AddedShares held: Q3 2020 385.7k, Q4 2020 380.0k, Q1 2021 423.0k, Q2 2021 448.5k +25.5k +25,500 6.0%
4 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 432,926 $35.9m9.32% 9.32% AddedShares held: Q3 2020 523.4k, Q4 2020 365.9k, Q1 2021 407.9k, Q2 2021 432.9k +25.0k +25,000 6.1%
5 UNIQURE NV SHS QURE QURE 1,157,513 $35.7m9.26% 9.26% AddedShares held: Q3 2020 631.1k, Q4 2020 702.0k, Q1 2021 955.4k, Q2 2021 1.2m +202.1k +202,089 21.1%
6 MAGENTA THERAPEUTICS INC COM COM 2,687,183 $26.3m6.83% 6.83% AddedShares held: Q3 2020 958.6k, Q4 2020 2.3m, Q1 2021 2.5m, Q2 2021 2.7m +185.0k +184,973 7.4%
7 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,194,237 $23.6m6.12% 6.12% AddedShares held: Q3 2020 1.0m, Q4 2020 1.0m, Q1 2021 1.1m, Q2 2021 1.2m +70.0k +70,000 6.2%
8 REGENXBIO INC COM RGNX RGNX 595,444 $23.1m6.01% 6.01% AddedShares held: Q3 2020 510.8k, Q4 2020 503.4k, Q1 2021 559.4k, Q2 2021 595.4k +36.0k +36,000 6.4%
9 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 945,382 $22.8m5.92% 5.92% AddedShares held: Q3 2020 0, Q4 2020 20.0k, Q1 2021 300.9k, Q2 2021 945.4k +644.5k +644,496 214.2%
10 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 1,140,000 $13.8m3.59% 3.59% AddedShares held: Q3 2020 0, Q4 2020 800.0k, Q1 2021 800.0k, Q2 2021 1.1m +340.0k +340,000 42.5%
11 PIERIS PHARMACEUTICALS INC COM COM 3,196,527 $12.2m3.18% 3.18% ReducedShares held: Q3 2020 3.7m, Q4 2020 3.7m, Q1 2021 3.7m, Q2 2021 3.2m -479.0k -479,003 -13.0%
12 HARPOON THERAPEUTICS INC COM COM 712,674 $9.9m2.57% 2.57% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 1.6m, Q2 2021 712.7k -841.5k -841,525 -54.1%
13 GALAPAGOS NV SPON ADR LKFT LKFT 142,340 $9.8m2.55% 2.55% AddedShares held: Q3 2020 32.5k, Q4 2020 70.0k, Q1 2021 116.7k, Q2 2021 142.3k +25.6k +25,617 21.9%
14 ARGENX SE SPONSORED ADR ARGX ARGX 21,200 $6.4m1.66% 1.66% UnchangedShares held: Q3 2020 7.5k, Q4 2020 12.7k, Q1 2021 21.2k, Q2 2021 21.2k
15 GENMAB A/S SPONSORED ADS GMAB GMAB 120,000 $4.9m1.27% 1.27% UnchangedShares held: Q3 2020 50.0k, Q4 2020 90.0k, Q1 2021 120.0k, Q2 2021 120.0k